IL214195A0 - Methods for amplifying hepatitis c virus nucleic acids - Google Patents
Methods for amplifying hepatitis c virus nucleic acidsInfo
- Publication number
- IL214195A0 IL214195A0 IL214195A IL21419511A IL214195A0 IL 214195 A0 IL214195 A0 IL 214195A0 IL 214195 A IL214195 A IL 214195A IL 21419511 A IL21419511 A IL 21419511A IL 214195 A0 IL214195 A0 IL 214195A0
- Authority
- IL
- Israel
- Prior art keywords
- methods
- nucleic acids
- virus nucleic
- amplifying hepatitis
- hepatitis
- Prior art date
Links
- 241000711549 Hepacivirus C Species 0.000 title 1
- 150000007523 nucleic acids Chemical class 0.000 title 1
- 102000039446 nucleic acids Human genes 0.000 title 1
- 108020004707 nucleic acids Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
- C12Q1/706—Specific hybridization probes for hepatitis
- C12Q1/707—Specific hybridization probes for hepatitis non-A, non-B Hepatitis, excluding hepatitis D
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2531/00—Reactions of nucleic acids characterised by
- C12Q2531/10—Reactions of nucleic acids characterised by the purpose being amplify/increase the copy number of target nucleic acid
- C12Q2531/113—PCR
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Pathology (AREA)
- Virology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US14608309P | 2009-01-21 | 2009-01-21 | |
| PCT/US2010/021589 WO2010090857A2 (en) | 2009-01-21 | 2010-01-21 | Methods for amplifying hepatitis c virus nucleic acids |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL214195A0 true IL214195A0 (en) | 2011-08-31 |
Family
ID=42334055
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL214195A IL214195A0 (en) | 2009-01-21 | 2011-07-19 | Methods for amplifying hepatitis c virus nucleic acids |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US8679740B2 (enExample) |
| EP (1) | EP2389452A2 (enExample) |
| JP (1) | JP2012515534A (enExample) |
| KR (1) | KR20120101278A (enExample) |
| CN (1) | CN102341506A (enExample) |
| AU (1) | AU2010210892A1 (enExample) |
| CA (1) | CA2749969A1 (enExample) |
| IL (1) | IL214195A0 (enExample) |
| MX (1) | MX2011007693A (enExample) |
| NZ (1) | NZ594155A (enExample) |
| RU (1) | RU2011134857A (enExample) |
| WO (1) | WO2010090857A2 (enExample) |
| ZA (1) | ZA201105349B (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX352987B (es) | 2007-10-02 | 2017-12-15 | Theranos Ip Co Llc | Dispositivos modulares de punto de cuidado y usos de los mismos. |
| CA2825196C (en) | 2011-01-21 | 2021-01-05 | Theranos, Inc. | Systems and methods for sample use maximization |
| US9619627B2 (en) | 2011-09-25 | 2017-04-11 | Theranos, Inc. | Systems and methods for collecting and transmitting assay results |
| US9632102B2 (en) | 2011-09-25 | 2017-04-25 | Theranos, Inc. | Systems and methods for multi-purpose analysis |
| US8475739B2 (en) | 2011-09-25 | 2013-07-02 | Theranos, Inc. | Systems and methods for fluid handling |
| US20140170735A1 (en) | 2011-09-25 | 2014-06-19 | Elizabeth A. Holmes | Systems and methods for multi-analysis |
| US9268915B2 (en) | 2011-09-25 | 2016-02-23 | Theranos, Inc. | Systems and methods for diagnosis or treatment |
| US8840838B2 (en) | 2011-09-25 | 2014-09-23 | Theranos, Inc. | Centrifuge configurations |
| US9664702B2 (en) | 2011-09-25 | 2017-05-30 | Theranos, Inc. | Fluid handling apparatus and configurations |
| US9250229B2 (en) | 2011-09-25 | 2016-02-02 | Theranos, Inc. | Systems and methods for multi-analysis |
| US10012664B2 (en) | 2011-09-25 | 2018-07-03 | Theranos Ip Company, Llc | Systems and methods for fluid and component handling |
| US9810704B2 (en) | 2013-02-18 | 2017-11-07 | Theranos, Inc. | Systems and methods for multi-analysis |
| CN105683751B (zh) | 2013-09-06 | 2020-01-17 | 赛拉诺斯知识产权有限责任公司 | 用于接收拭子的装置、系统、方法和套件 |
| BR112016004994A2 (pt) | 2013-09-06 | 2021-05-11 | Theranos Ip Company, Llc | Sistemas e métodos para detectar doenças infecciosas |
| CN106222306A (zh) * | 2016-08-30 | 2016-12-14 | 合肥金域医学检验所有限公司 | 一种hcv病毒ns5a蛋白编码序列突变检测试剂盒 |
| GB201819726D0 (en) * | 2018-12-03 | 2019-01-16 | Diagnostics For The Real World Ltd | HCV detection |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4458066A (en) | 1980-02-29 | 1984-07-03 | University Patents, Inc. | Process for preparing polynucleotides |
| US4415732A (en) | 1981-03-27 | 1983-11-15 | University Patents, Inc. | Phosphoramidite compounds and processes |
| US4973679A (en) | 1981-03-27 | 1990-11-27 | University Patents, Inc. | Process for oligonucleo tide synthesis using phosphormidite intermediates |
| DE3329892A1 (de) | 1983-08-18 | 1985-03-07 | Köster, Hubert, Prof. Dr., 2000 Hamburg | Verfahren zur herstellung von oligonucleotiden |
| FR2596761B1 (fr) | 1986-04-08 | 1988-05-20 | Commissariat Energie Atomique | Derives de nucleosides et leur utilisation pour la synthese d'oligonucleotides |
| US5322770A (en) | 1989-12-22 | 1994-06-21 | Hoffman-Laroche Inc. | Reverse transcription with thermostable DNA polymerases - high temperature reverse transcription |
| US5310652A (en) | 1986-08-22 | 1994-05-10 | Hoffman-La Roche Inc. | Reverse transcription with thermostable DNA polymerase-high temperature reverse transcription |
| EP0787807B1 (en) | 1991-08-27 | 2003-05-28 | F. Hoffmann-La Roche Ag | Primers and probes for hepatitis C detection |
| EP0532258A2 (en) * | 1991-09-09 | 1993-03-17 | Immuno Japan Inc. | Oligonucleotides and determination system of HCV genotypes |
| JPH0775585A (ja) * | 1993-06-14 | 1995-03-20 | Immuno Japan:Kk | Ｃ型肝炎ウイルス関連オリゴヌクレオチドならびにｃ型肝炎 ウイルス遺伝子型判定方法 |
| ZA966663B (en) | 1995-08-17 | 1998-02-06 | Genentech Inc | Traf Inhibitors. |
| US6153421A (en) * | 1997-07-18 | 2000-11-28 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Cloned genomes of infectious hepatitis C viruses and uses thereof |
| WO2002064842A2 (en) * | 2001-02-13 | 2002-08-22 | Children`S Hospital Research Foundation | Quantitative epstein barr virus pcr rapid assay |
| JP3751867B2 (ja) * | 2001-09-18 | 2006-03-01 | 株式会社東芝 | インターフェロンを投与されるべき個体においてインターフェロン療法の有効性を予測する方法、その方法をコンピュータにより実行させるためのプログラム、インターフェロン感受性に関連する多型部位の遺伝子型を検出するための核酸プローブ、およびその核酸プローブを具備する塩基配列検出用チップ |
| AU2003230790A1 (en) * | 2002-04-03 | 2003-10-20 | Smithkline Beecham Corporation | Hepatitis c virus sub-genomic replicons |
| US20040137539A1 (en) * | 2003-01-10 | 2004-07-15 | Bradford Sherry A. | Cancer comprehensive method for identifying cancer protein patterns and determination of cancer treatment strategies |
| WO2004073599A2 (en) | 2003-02-18 | 2004-09-02 | Pfizer Inc. | Inhibitors of hepatitis c virus, compositions and treatments using the same |
| US20050282179A1 (en) | 2003-12-05 | 2005-12-22 | Applera Corporation | Biomarkers for interferon-alpha response in hepatitis C virus infected patients |
| JPWO2006085407A1 (ja) * | 2005-02-09 | 2008-12-18 | 学校法人日本大学 | Ｈｃｖ量に関連する遺伝子のスクリーニング方法 |
| EP2711427A1 (en) * | 2007-04-27 | 2014-03-26 | Advanced Life Science Institute, Inc. | HCV gene |
| JP4213759B2 (ja) * | 2007-08-10 | 2009-01-21 | 株式会社東芝 | 標的核酸の遺伝子型、および変異の判定方法、不溶性支持体に核酸断片を固定化する方法、所望の核酸を精製し、かつ増幅するための方法、並びに遺伝子型アッセイキット |
-
2010
- 2010-01-21 AU AU2010210892A patent/AU2010210892A1/en not_active Abandoned
- 2010-01-21 CN CN2010800098527A patent/CN102341506A/zh active Pending
- 2010-01-21 NZ NZ594155A patent/NZ594155A/xx not_active IP Right Cessation
- 2010-01-21 CA CA2749969A patent/CA2749969A1/en not_active Abandoned
- 2010-01-21 JP JP2011546450A patent/JP2012515534A/ja active Pending
- 2010-01-21 WO PCT/US2010/021589 patent/WO2010090857A2/en not_active Ceased
- 2010-01-21 KR KR1020117019326A patent/KR20120101278A/ko not_active Withdrawn
- 2010-01-21 MX MX2011007693A patent/MX2011007693A/es not_active Application Discontinuation
- 2010-01-21 EP EP10703544A patent/EP2389452A2/en not_active Ceased
- 2010-01-21 RU RU2011134857/10A patent/RU2011134857A/ru not_active Application Discontinuation
-
2011
- 2011-07-19 IL IL214195A patent/IL214195A0/en unknown
- 2011-07-20 ZA ZA2011/05349A patent/ZA201105349B/en unknown
- 2011-07-20 US US13/186,985 patent/US8679740B2/en not_active Expired - Fee Related
-
2014
- 2014-01-28 US US14/165,757 patent/US20140199684A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CN102341506A (zh) | 2012-02-01 |
| WO2010090857A2 (en) | 2010-08-12 |
| KR20120101278A (ko) | 2012-09-13 |
| WO2010090857A8 (en) | 2012-06-28 |
| AU2010210892A1 (en) | 2011-08-11 |
| NZ594155A (en) | 2013-02-22 |
| CA2749969A1 (en) | 2010-08-12 |
| US8679740B2 (en) | 2014-03-25 |
| US20140199684A1 (en) | 2014-07-17 |
| WO2010090857A3 (en) | 2010-11-25 |
| MX2011007693A (es) | 2011-09-27 |
| US20120129155A1 (en) | 2012-05-24 |
| EP2389452A2 (en) | 2011-11-30 |
| ZA201105349B (en) | 2013-10-30 |
| JP2012515534A (ja) | 2012-07-12 |
| RU2011134857A (ru) | 2013-02-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA201105349B (en) | Methods for amplifying hepatitis c virus nucleic acids | |
| HUS1500019I1 (hu) | Hepatitisz C vírus inhibitorok | |
| IL219516A0 (en) | Hepatitis c virus inhibitors | |
| IL219517A0 (en) | Hepatitis c virus inhibitors | |
| ZA201106629B (en) | Hepatitis c virus inhibitors | |
| ZA201105722B (en) | Hepatitis c virus inhibitors | |
| IL215055A0 (en) | Hepatitis c virus inhibitors | |
| IL214939A0 (en) | Hepatitis c virus inhibitors | |
| EP2475256A4 (en) | HEPATITIS C-VIRUS HEMMER | |
| ZA201107095B (en) | Hepatitis c virus inhibitors | |
| EP2512480A4 (en) | HEPATITIS C-VIRUS HEMMER | |
| IL207459A0 (en) | Hepatitis c virus inhibitors | |
| IL207470A0 (en) | Hepatitis c virus inhibitors | |
| IL221033A0 (en) | Hepatitis c virus inhibitors | |
| EP2575819A4 (en) | INHIBITORS OF HEPATITIS C VIRUS | |
| IL224298A (en) | Hepatitis virus inhibitors c | |
| EP2603080A4 (en) | HEPATITIS C-VIRUS HEMMER | |
| SI2368890T1 (sl) | Inhibitorji virusa hepatitisa C | |
| HK1164644A (en) | Hepatitis c virus inhibitors | |
| HK1168358A (en) | Hepatitis c virus inhibitors | |
| HK1177738A (en) | Hepatitis c virus inhibitors | |
| HK1160858A (en) | Hepatitis c virus inhibitors | |
| HK1161243A (en) | Hepatitis c virus inhibitors | |
| HK1168356A (en) | Hepatitis c virus inhibitors | |
| HK1160857A (en) | Hepatitis c virus inhibitors |